Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Share Capital

Bulletin Express

Nov 25

Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 25 November 2025. According to the announcement, the company repurchased 23,200 H shares on the Hong Kong Stock Exchange. The highest repurchase price was HKD 20.46, while the lowest price was HKD 20.2, with a total payment of approximately HKD 472,727.84. These repurchased shares are held as treasury shares.

Following this transaction, the number of issued shares (excluding treasury shares) decreased from 226,193,000 to 226,169,800, and treasury shares increased from 878,600 to 901,800. The total number of issued shares remained at 227,071,600. The repurchase accounted for around 0.0103% of the company’s previously issued shares (excluding treasury shares). The stated repurchase mandate was granted on 20 June 2025, with an authorized limit of 22,207,160 shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1158450888"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1158450888\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1158450888?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-25 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158450888","market":"hk","top_or_hot":-1,"title":"Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Share Capital","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 25 November 2025. According to the announcement, the company repurchased 23,200 H shares on the Hong Kong Stock Exchange. The highest repurchase price was HKD 20.46, while the lowest price was HKD 20.2, with a total payment of approximately HKD 472,727.84. These repurchased shares are held as treasury shares.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) decreased from 226,193,000 to 226,169,800, and treasury shares increased from 878,600 to 901,800. The total number of issued shares remained at 227,071,600. The repurchase accounted for around 0.0103% of the company’s previously issued shares (excluding treasury shares). The stated repurchase mandate was granted on 20 June 2025, with an authorized limit of 22,207,160 shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Share Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics (02509) Announces Share Repurchase and Updated Share Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-25 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 25 November 2025. According to the announcement, the company repurchased 23,200 H shares on the Hong Kong Stock Exchange. The highest repurchase price was HKD 20.46, while the lowest price was HKD 20.2, with a total payment of approximately HKD 472,727.84. These repurchased shares are held as treasury shares.</p>\n<p>Following this transaction, the number of issued shares (excluding treasury shares) decreased from 226,193,000 to 226,169,800, and treasury shares increased from 878,600 to 901,800. The total number of issued shares remained at 227,071,600. The repurchase accounted for around 0.0103% of the company’s previously issued shares (excluding treasury shares). The stated repurchase mandate was granted on 20 June 2025, with an authorized limit of 22,207,160 shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1158450888","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158450888","pubTimestamp":1764072211,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 25 November 2025. According to the announcement, the company repurchased 23,200 H shares on the Hong Kong Stock Exchange. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics(02509)公布购回股份及更新股本","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 25 November 2025. According to the announcement, the company repurchased 23,200 H shares on the Hong Kong Stock Exchange. The highest repurchase price was HKD 20.46, while the lowest price was HKD 20.2, with a total payment of approximately HKD 472,727.84. These repurchased shares are held as treasury shares.\nFollowing this transaction, the number of issued shares (excluding treasury shares) decreased from 226,193,000 to 226,169,800, and treasury shares increased from 878,600 to 901,800. The total number of issued shares remained at 227,071,600. The repurchase accounted for around 0.0103% of the company’s previously issued shares (excluding treasury shares). The stated repurchase mandate was granted on 20 June 2025, with an authorized limit of 22,207,160 shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}